Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats

por Gunarathne, Lakmie S., Angus, Peter W., Herath, Chandana B.
Publicado 2019

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

por Herath, Chandana B., Angus, Peter W., Trebicka, Jonel
Publicado 2022

Current therapies and novel approaches for biliary diseases

por Rajapaksha, Indu G, Angus, Peter W, Herath, Chandana B
Publicado 2019

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis

por Grace, Josephine A., Casey, Stephen, Burrell, Louise M., Angus, Peter W.
Publicado 2020

Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options

por Rajapaksha, Indu G., Gunarathne, Lakmie S., Angus, Peter W., Herath, Chandana B.
Publicado 2021

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products

por Fernando, Dinali H., Forbes, Josephine M., Angus, Peter W., Herath, Chandana B.
Publicado 2019

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

por Gunarathne, Lakmie S, Rajapaksha, Harinda, Shackel, Nicholas, Angus, Peter W, Herath, Chandana B
Publicado 2020

Changes in the renin angiotensin system during the development of colorectal cancer liver metastases

por Neo, Jaclyn H, Ager, Eleanor I, Angus, Peter W, Zhu, Jin, Herath, Chandana B, Christophi, Christopher
Publicado 2010

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation

por Lim, Eu Jin, Chin, Ruth, Nachbur, Ueli, Silke, John, Jia, Zhiyuan, Angus, Peter W., Torresi, Joseph
Publicado 2015

The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice

por Rajapaksha, Indu G., Mak, Kai Y., Huang, Ping, Burrell, Louise M., Angus, Peter W., Herath, Chandana B.
Publicado 2018

Long‐term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation

por Vasudevan, Abhinav, Ardalan, Zaid S, Ahmed, Navera, Apostolov, Ross, Gow, Paul J, Testro, Adam G, Gane, Ed J, Angus, Peter W
Publicado 2018

Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice

por Rajapaksha, Indu G., Gunarathne, Lakmie S., Asadi, Khashayar, Cunningham, Sharon C., Sharland, Alexandra, Alexander, Ian E., Angus, Peter W., Herath, Chandana B.
Publicado 2019

Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats

por Gunarathne, Lakmie S., Rajapaksha, Indu G., Casey, Stephen, Qaradakhi, Tawar, Zulli, Anthony, Rajapaksha, Harinda, Trebicka, Jonel, Angus, Peter W., Herath, Chandana B.
Publicado 2022

Alcohol intake is associated with a decreased risk of developing primary biliary cholangitis

por French, Janine Adele, Gow, Paul, Simpson-Yap, Steven, Collins, Kate, Ng, Justin, Angus, Peter W, van der Mei, Ingrid A F
Publicado 2022

To TOE or not to TOE? That is the question in patients with portal hypertension and varices

por Leung, Christopher, Yeoh, Sern Wei, Lim, Lucy Y, Boyapati, Ray, Testro, Adam G, Vaughan, Rhys, Marion, Kaye, Burrell, Louise M, Angus, Peter W
Publicado 2013

Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver

por Rajapaksha, Indu G., Gunarathne, Lakmie S., Asadi, Khashayar, Laybutt, Ross, Andrikopoulous, Sof, Alexander, Ian E., Watt, Mathew J., Angus, Peter W., Herath, Chandana B.
Publicado 2021

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

por Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Publicado 2007

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis

por Klein, Sabine, Herath, Chandana B., Schierwagen, Robert, Grace, Josephine, Haltenhof, Tom, Uschner, Frank E., Strassburg, Christian P., Sauerbruch, Tilman, Walther, Thomas, Angus, Peter W., Trebicka, Jonel
Publicado 2015

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

por Leung, Christopher, Herath, Chandana B, Jia, Zhiyuan, Andrikopoulos, Sof, Brown, Bronwyn E, Davies, Michael J, Rivera, Leni R, Furness, John B, Forbes, Josephine M, Angus, Peter W
Publicado 2016

Epidemiology and outcomes of acute liver failure in Australia

por Hey, Penelope, Hanrahan, Timothy P, Sinclair, Marie, Testro, Adam G, Angus, Peter W, Peterson, Adam, Warrillow, Stephen, Bellomo, Rinaldo, Perini, Marcos V, Starkey, Graham, Jones, Robert M, Fink, Michael, McClure, Tess, Gow, Paul
Publicado 2019